Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,265,800 shares, representing 1.64% for ¥9,999.82 million.
November 01, 2022 at 03:00 am EDT
Share
Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) announces a share repurchase program. Under the program, the company will repurchase up to 1,265,800 shares, representing 1.64% of its issued share capital for ¥9,999.82 million. The shares will be repurchased at a price of ¥7,200 per share. The purpose of the program is to further return profits to shareholders and implement a flexible capital policy that responds to changes in the business environment. The program is valid till November 2, 2022. As of September 30, 2022, the company had 77,279,714 shares issued (excluding treasury stock) and 4,770,286 shares in treasury.
On February 17, 2023, the company announced the final number of shares repurchased after the determination of post-adjustment. Under the program, the final number of shares to be acquired are 1,151,700 shares.
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.